> R&D > Publication
[pH-dependent B7H3 ADC] 2025 AACR Poster Presentation
A next generation ADC : AR153, PH-dependent anti-B7-H3-MMAE
[AR166 전임상] 2026년 AACR 발표 포스터
AR166, a First-in-Class PD-1xLAG-3xIL-2v Tri-specific Immunocytokine Delivering Cis-Acting IL-2v to Overcome Immune Checkpoint Inhibitor Resistance.
[AR170 전임상] 2026년 AACR 발표 포스터
AR170, a novel PD-1xVEGFxIL-2v tri-specific immunocytokine to redefine next generation cancer immunotherapy
[pH-감응 B7H3 ADC] 제30회 연세 송당 국제 암 심포지엄 초록
AR153, a novel pH-dependent anti-B7-H3 ADC with MMAE payload
[pH-dependent B7H3 ADC] 2025 AACR Poster Presentation
A next generation ADC : AR153, PH-dependent anti-B7-H3-MMAE
[TGF-b SelecTrap] 2024 SITC Poster Presentation
[HLA-G ALiCE] 2024 SITC Poster Presentation
AR092, a proprietary HLA-G/CD3 T cell engager,
induces anti-tumor activity and minimal toxicity in solid tumors
[CD39 Antibody] 2024 AACR Poster Presentation
Discovery and Evaluation of AR062, anti-CD39 mAb for the treatment of cancer
[YBL-006 Clinical Results] 2023 SITC Poster Presentation
Safety and Efficacy of YBL-006, a Novel Anti PD 1 Antibody, in Advanced
Solid Tumors Including G3 NET/NEC: Results From a Phase 1/2a Study
[YBL-006 Interim Clinical Results Poster] 2021 ESMO Poster Presentation
Interim results of phase 1 dose escalation study of YBL-006,
a novel anti-PD-1 monoclonal antibody in advanced solid tumors
[PD-L1 ALiCE] Biomaterials 271 (2021) 120760 Published Paper
Development of an antibody-like T-cell engager based on VH-VL
heterodimer formation and its application in cancer therapy
[YBL-006 Preclinical Results] 2020 AACR Poster Presentation
Preclinical Characterization of YBL-006,
a Fully Human Anti-PD-1 Antibody Being Ready for Clinical Studies
[PD-L1 ALiCE] 2018 Protein Engineering Summit Poster Presentation
The making of Antibody Like (T) Cell Engager on the basis of VH-VL
heterodimer formation and its application in cancer therapy
[PD-L1 ALiCE] 2018 BsAB Congress Poster Presentation
The making of Antibody Like (T) Cell Engager on the basis of VH-VL
heterodimer formation and its application in cancer therapy
[B7H3 Antibody] 2018 Protein Engineering Summit Poster Presentation
Screening and Characterization of B7-H3-specific human antibody